NFKB1 and metabolic dysfunction-associated steatohepatitis: Through experiments [69], the NF-κB signaling pathway can lead to liver fibrosis through miR-378, as miR-378 leads to the development of NASH and liver fibrosis by promoting the activation of the NFκB-TNFα axis.